245 related articles for article (PubMed ID: 16534035)
21. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
[TBL] [Abstract][Full Text] [Related]
22. Working with reactant patients: are we prescribing nonadherence?
Madsen JW; McQuaid JR; Craighead WE
Depress Anxiety; 2009; 26(2):129-34. PubMed ID: 18972363
[TBL] [Abstract][Full Text] [Related]
23. Antidepressant use: concordance between self-report and claims records.
Kwon A; Bungay KM; Pei Y; Rogers WH; Wilson IB; Zhou Q; Adler DA
Med Care; 2003 Mar; 41(3):368-74. PubMed ID: 12618640
[TBL] [Abstract][Full Text] [Related]
24. Collaborative management to achieve treatment guidelines. Impact on depression in primary care.
Katon W; Von Korff M; Lin E; Walker E; Simon GE; Bush T; Robinson P; Russo J
JAMA; 1995 Apr; 273(13):1026-31. PubMed ID: 7897786
[TBL] [Abstract][Full Text] [Related]
25. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp).
Bryson CL; Au DH; Young B; McDonell MB; Fihn SD
Med Care; 2007 Jun; 45(6):497-504. PubMed ID: 17515776
[TBL] [Abstract][Full Text] [Related]
26. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).
Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457
[TBL] [Abstract][Full Text] [Related]
27. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
28. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
[TBL] [Abstract][Full Text] [Related]
29. Clinical factors associated with relapse in primary care patients with chronic or recurrent depression.
Gopinath S; Katon WJ; Russo JE; Ludman EJ
J Affect Disord; 2007 Aug; 101(1-3):57-63. PubMed ID: 17156852
[TBL] [Abstract][Full Text] [Related]
30. Enhancing patient outcomes: treatment adherence.
Frank E
J Clin Psychiatry; 1997; 58 Suppl 1():11-4. PubMed ID: 9054903
[TBL] [Abstract][Full Text] [Related]
31. Costs of antidepressant medications associated with inadequate treatment.
Weilburg JB; Stafford RS; O'Leary KM; Meigs JB; Finkelstein SN
Am J Manag Care; 2004 Jun; 10(6):357-65. PubMed ID: 15209479
[TBL] [Abstract][Full Text] [Related]
32. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
33. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.
Hess LM; Raebel MA; Conner DA; Malone DC
Ann Pharmacother; 2006; 40(7-8):1280-88. PubMed ID: 16868217
[TBL] [Abstract][Full Text] [Related]
34. An interactive voice response system to enhance antidepressant medication compliance.
Stuart GW; Laraia MT; Ornstein SM; Nietert PJ
Top Health Inf Manage; 2003; 24(1):15-20. PubMed ID: 12674391
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
Quigley HA; Friedman DS; Hahn SR
Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
[TBL] [Abstract][Full Text] [Related]
36. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation.
Smith DH; Perrin N; Feldstein A; Yang X; Kuang D; Simon SR; Sittig DF; Platt R; Soumerai SB
Arch Intern Med; 2006 May; 166(10):1098-104. PubMed ID: 16717172
[TBL] [Abstract][Full Text] [Related]
37. Young HIV-infected adults are at greater risk for medication nonadherence.
Becker SL; Dezii CM; Burtcel B; Kawabata H; Hodder S
MedGenMed; 2002 Jul; 4(3):21. PubMed ID: 12466764
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
39. Inadequate follow-up care for depression and its impact on antidepressant treatment duration among veterans with and without diabetes mellitus in the Veterans Health Administration.
Jones LE; Turvey C; Carney-Doebbeling C
Gen Hosp Psychiatry; 2006; 28(6):465-74. PubMed ID: 17088161
[TBL] [Abstract][Full Text] [Related]
40. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
